8.29
price up icon1.36%   0.18
after-market Dopo l'orario di chiusura: 8.30 0.01 +0.12%
loading
Precedente Chiudi:
$8.11
Aprire:
$8.15
Volume 24 ore:
63,631
Relative Volume:
0.68
Capitalizzazione di mercato:
$77.50M
Reddito:
$24.99M
Utile/perdita netta:
$-108.83M
Rapporto P/E:
-0.5516
EPS:
-15.0286
Flusso di cassa netto:
$-91.62M
1 W Prestazione:
-10.75%
1M Prestazione:
-6.91%
6M Prestazione:
+20.70%
1 anno Prestazione:
-13.86%
Intervallo 1D:
Value
$7.925
$8.29
Intervallo di 1 settimana:
Value
$7.42
$9.50
Portata 52W:
Value
$6.01
$17.44

Adicet Bio Inc Stock (ACET) Company Profile

Name
Nome
Adicet Bio Inc
Name
Telefono
617-482-2333
Name
Indirizzo
131 DARTMOUTH STREET, BOSTON
Name
Dipendente
102
Name
Cinguettio
Name
Prossima data di guadagno
2026-08-06
Name
Ultimi documenti SEC
Name
ACET's Discussions on Twitter

Compare ACET vs VRTX, REGN, ARGX, RVMD, ONC

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
ACET icon
ACET
Adicet Bio Inc
8.29 75.35M 24.99M -108.83M -91.62M -15.03
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
529.86 121.57B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
797.00 69.95B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
863.86 55.61B 4.16B 1.29B 734.26M 19.58
RVMD icon
RVMD
Revolution Medicines Inc
205.55 39.98B 742.00K -1.37B -1.07B -7.0731
ONC icon
ONC
Beone Medicines Ltd Adr
359.27 33.81B 5.76B 514.49M 1.10B 4.4813

Adicet Bio Inc Stock (ACET) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-09-30 Ripresa Guggenheim Buy
2024-09-11 Downgrade H.C. Wainwright Buy → Neutral
2023-06-27 Downgrade Guggenheim Buy → Neutral
2023-06-27 Downgrade JMP Securities Mkt Outperform → Mkt Perform
2023-06-01 Downgrade JP Morgan Overweight → Neutral
2022-09-21 Iniziato JP Morgan Overweight
2022-03-31 Iniziato SMBC Nikko Outperform
2022-03-08 Iniziato Truist Buy
2022-03-04 Iniziato Jefferies Buy
2021-05-18 Iniziato BTIG Research Buy
2021-04-23 Iniziato H.C. Wainwright Buy
2021-04-14 Iniziato Canaccord Genuity Buy
2021-04-08 Iniziato Guggenheim Buy
2020-11-04 Iniziato B. Riley Securities Buy
2020-10-27 Iniziato JMP Securities Mkt Outperform
2020-10-16 Iniziato Wedbush Outperform
Mostra tutto

Adicet Bio Inc Borsa (ACET) Ultime notizie

pulisher
Jul 27, 2026

Adicet Bio, Inc. Revenue Breakdown – NASDAQ:ACET - TradingView

Jul 27, 2026
pulisher
Jul 27, 2026

Adicet Bio Inc (ACET) Balance Sheet - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Adicet Bio Inc (ACET) Cash Flow - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Adicet Bio: A 400% Upside Bet on Gamma Delta T-Cell Data - Kavout | AI

Jul 27, 2026
pulisher
Jul 27, 2026

Adicet Bio Inc Revenue Breakdown – TRADEGATE:1IJ - TradingView

Jul 27, 2026
pulisher
Jul 27, 2026

Adicet Bio Inc (ACET) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jul 27, 2026
pulisher
Jul 26, 2026

TradingKey - TradingKey

Jul 26, 2026
pulisher
Jul 26, 2026

Adicet Bio Inc (ACET) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jul 26, 2026
pulisher
Jul 26, 2026

Adicet Bio Inc (ACET) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jul 26, 2026
pulisher
Jul 26, 2026

Adicet Bio Inc (ACET) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jul 26, 2026
pulisher
Jul 26, 2026

ACET|Adicet Bio Inc|Price:8.140|Chg%:+0.350 - TradingKey

Jul 26, 2026
pulisher
Jul 25, 2026

Adicet Bio Market Sentiment - Benzinga España

Jul 25, 2026
pulisher
Jul 24, 2026

Adicet Bio Inc (ACET) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jul 24, 2026
pulisher
Jul 23, 2026

Adicet Bio Inc (ACET) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jul 23, 2026
pulisher
Jul 22, 2026

Adicet Bio to Participate in Fireside Chat at Canaccord Genuity 46th Annual Growth Conference - BioSpace

Jul 22, 2026
pulisher
Jul 13, 2026

CCORF Maintains Adicet Bio(ACET.US) With Buy Rating, Maintains Target Price $18 - Moomoo

Jul 13, 2026
pulisher
Jul 11, 2026

Price to earnings forward of Adicet Bio, Inc. – NASDAQ:ACET - TradingView

Jul 11, 2026
pulisher
Jul 11, 2026

Enterprise value to revenue forward of Adicet Bio, Inc. – NASDAQ:ACET - TradingView

Jul 11, 2026
pulisher
Jul 11, 2026

ACET Q1 2026 Earnings: Narrower Loss Beats Expectations Amid Pre-Revenue StageRevenue Surprise History - dars.gov.et

Jul 11, 2026
pulisher
Jul 09, 2026

Adicet Bio (ACET) Proxy filing Summary - Quartr

Jul 09, 2026
pulisher
Jul 09, 2026

Are medical stocks lagging Adicet Bio (ACET) this year? - MSN

Jul 09, 2026
pulisher
Jul 04, 2026

Adicet Bio (ACET) Stock Analysis Report | Financials & Insights - Benzinga España

Jul 04, 2026
pulisher
Jul 01, 2026

Is Adicet Bio (ACET) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Jul 01, 2026
pulisher
Jun 29, 2026

Adicet Bio, Inc.(NasdaqCM: ACET) added to Russell Microcap Value Benchmark Index - marketscreener.com

Jun 29, 2026
pulisher
Jun 29, 2026

Adicet Bio, Inc.(NasdaqCM: ACET) added to Russell Microcap Index - marketscreener.com

Jun 29, 2026
pulisher
Jun 28, 2026

Adicet Bio, Inc.(NasdaqCM: ACET) added to Russell 3000E Index - marketscreener.com

Jun 28, 2026
pulisher
Jun 28, 2026

ACET Q1 2026 Earnings: Smaller-Than-Expected Loss Drives Shares HigherBook Value Growth - dars.gov.et

Jun 28, 2026
pulisher
Jun 26, 2026

1IJ Forecast — Price Target — Prediction for 2027 - TradingView

Jun 26, 2026
pulisher
Jun 26, 2026

Adicet Bio Inc Actuals & Estimates (MUN:1IJ) - TradingView

Jun 26, 2026
pulisher
Jun 26, 2026

ACET Forecast — Price Target — Prediction for 2027 - TradingView

Jun 26, 2026
pulisher
Jun 25, 2026

Adicet Bio Inc Actuals & Estimates (TRADEGATE:1IJ) - TradingView

Jun 25, 2026
pulisher
Jun 25, 2026

12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga

Jun 25, 2026
pulisher
Jun 23, 2026

Form 4 Adicet Bio Inc For: 23 June By Investing.com - Investing.com Nigeria

Jun 23, 2026
pulisher
Jun 23, 2026

Adicet Bio (ACET) CEO Chen Schor receives 55,000 stock options at $8.10 - Stock Titan

Jun 23, 2026
pulisher
Jun 23, 2026

Adicet Bio (ACET) grants CSO Blake Aftab 55,000 stock options - Stock Titan

Jun 23, 2026
pulisher
Jun 23, 2026

Director at Adicet Bio (NASDAQ: ACET) receives 4,200 stock options grant - Stock Titan

Jun 23, 2026
pulisher
Jun 23, 2026

Director at Adicet Bio (ACET) awarded 4,200 options at $8.10 strike - Stock Titan

Jun 23, 2026
pulisher
Jun 23, 2026

Adicet Bio (ACET) director receives stock options for 4,200 shares at $8.10 - Stock Titan

Jun 23, 2026
pulisher
Jun 23, 2026

Adicet Bio (ACET) director receives 4,200 stock options at $8.10 strike - Stock Titan

Jun 23, 2026
pulisher
Jun 23, 2026

Director Katie Peng receives 4,200 Adicet Bio (ACET) stock options at $8.10 - Stock Titan

Jun 23, 2026
pulisher
Jun 23, 2026

Director at Adicet Bio (ACET) receives 4,200 stock options award - Stock Titan

Jun 23, 2026
pulisher
Jun 23, 2026

ACET Q1 2026 Earnings: EPS Beats Estimates by 40.7% as Clinical Progress ContinuesEBITDA Analysis - dars.gov.et

Jun 23, 2026
pulisher
Jun 18, 2026

Adicet Bio Stockholders Back Directors, Pay and Auditor - TipRanks

Jun 18, 2026
pulisher
Jun 18, 2026

Adicet Bio (ACET) investors back board nominees, pay and KPMG at 2026 meeting - Stock Titan

Jun 18, 2026
pulisher
Jun 18, 2026

Adicet Bio Inc (ACET) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jun 18, 2026
pulisher
Jun 17, 2026

Adicet Bio Inc (ACET) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Adicet Bio Inc (ACET) Institutional Confidence - TradingKey

Jun 17, 2026

Adicet Bio Inc Azioni (ACET) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Adicet Bio Inc Azioni (ACET) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
RA CAPITAL MANAGEMENT, L.P.
10% Owner
Feb 19 '26
Buy
7.21
74,268
535,472
1,107,873
RA CAPITAL MANAGEMENT, L.P.
10% Owner
Feb 18 '26
Buy
7.04
74,577
525,022
1,033,605
ORBIMED ADVISORS LLC
10% Owner
Apr 08 '26
Sale
6.42
72,939
468,082
0
ORBIMED ADVISORS LLC
10% Owner
Apr 07 '26
Sale
6.52
31,719
206,765
32,523
$121.07
price down icon 0.35%
$35.25
price down icon 1.38%
$57.79
price down icon 0.19%
$132.57
price down icon 1.66%
$221.20
price up icon 1.74%
ONC ONC
$359.27
price up icon 0.14%
Capitalizzazione:     |  Volume (24 ore):